Back in Time is ED’s newspaper-like column that reports an incident from the past as though it happened just yesterday. It allows the reader to re-live it several years later, on the date it occurred.
November 16, 1938: Yesterday, a quiet yet profound milestone emerged from the laboratories of Sandoz in Basel, Switzerland, where chemist Dr Albert Hofmann announced the synthesis of a unique compound, he calls, Lysergic Acid Diethylamide, or LSD.
Derived from the notoriously dangerous ergot fungus, LSD is an ergotamine derivative, initially created as Sandoz’s ongoing research into circulatory and respiratory stimulants. Early reports suggest that, unlike its deadly parent compound, LSD might harness the ergot’s potency while minimising its toxic effects, possibly transforming it into a wonder drug.
A New Chapter For Ergot, Europe’s Historical ‘Mass Poison’
The ergot fungus, a parasitic blight found on rye, has for centuries cast a dark shadow over Europe, linked to catastrophic epidemics known as St. Anthony’s Fire. Ingested by unwitting villagers, contaminated rye induced severe symptoms — from gangrene to muscle spasms, hallucinations, and psychosis. These outbreaks, often seen as acts of divine or supernatural punishment, afflicted countless lives.
In recent years, scientists understood that ergot contained psychoactive and vasoconstrictive compounds, which could be isolated and studied for medicinal use. This research led to discoveries of muscle relaxants and coagulating agents, opening up new medical pathways while raising unsettling questions about safety.
Read More: Back In Time: Today CV Raman Announced His Nobel Prize Winning Discovery 96 Years Back
Pioneering The Future Of Psychiatry?
Hofmann’s journey to synthesise LSD-25 (the 25th iteration of his experiments with lysergic acid and diethylamine) began with curiosity about the effects of combining ergot-derived compounds with other organic molecules.
Unlike previous ergot derivatives, LSD showed distinctive properties that have piqued researchers’ interest, potentially offering insights into the human mind itself.
However, initial animal trials have yielded mixed results, with reports of hyperactivity, odd movements, and signs of heightened agitation.
Despite these findings, the Sandoz laboratory remains optimistic. As they refine LSD’s chemical composition, they anticipate its potential to treat psychological ailments or open new areas of psychiatric research. The lab has praised Dr Hofmann’s dedication, though cautious whispers suggest that careful human testing may be needed to understand the limits of this compound truly.
The Public Eye On Sandoz
Public interest in Hofmann’s discovery has risen. Stories of ergot poisoning haunt the European collective memory, but curiosity about LSD’s potential therapeutic benefits remains strong. Swiss readers speculate whether Sandoz’s “wonder drug” might eventually relieve pain, calm nervous afflictions, or support mental well-being.
However, questions remain about LSD’s potential side effects: Will its users risk psychotic experiences or erratic behaviour? Will it be safe enough to use in medicine? Clinical trials in the coming years may provide answers.
Post Scriptum
Today, it’s hard to ignore how LSD’s legacy has expanded beyond the lab. While Switzerland and America have led early explorations into this mind-altering drug, even in far-off India, whispers of the “LSD craze” are making their way into public discourse.
Indian youth, charmed by Western ideals, are reportedly drawn to mind-expanding experiences, influenced by global pop culture. From high-society parties in Mumbai to spiritual seekers in Goa, LSD has developed a kind of mythical allure.
Indian celebrities and influencers seem particularly susceptible to its appeal, finding themselves “lost in the pursuit of the higher mind” and leading followers down risky paths. Some people joke, “Looks like LSD has replaced wisdom in today’s youth as the gateway to ‘enlightenment’!”
Amidst warnings from authorities, it seems LSD is giving India’s youth the ultimate lesson in irony: an ergot-derived path to clarity that might leave a trail of confusion and chaos in its wake.
Image Credits: Google Images
Sources: The Guardian, Rolling Stone, The Atlantic
Find the blogger: Katyayani Joshi
This post is tagged under: LSD, Albert Hofmann, Ergot, History of Drugs, Psychedelics, Drug Discovery, Medical Breakthrough, 1930s Science, Swiss Chemist, Cultural Revolution, Mental Health, Psychiatry, India Drug Scene, Youth Culture, Celebrity Scandals, Modern Drug Abuse, Ergot Poisoning, Hallucinogens, Drug Awareness, Responsible Science
Disclaimer: We do not hold any right, or copyright over any of the images used, these have been taken from Google. In case of credits or removal, the owner may kindly mail us.
Other Recommendations:
Karnataka’s “LSD King” Runs Online Drug Racket From Prison Cell
Karnataka’s “LSD King” Runs Online Drug Racket From Prison Cell
